http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2742655-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ad011f708286dadb45d6fcf7b2a6e48
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34
filingDate 2019-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d222439b4ad23ea2f304179e62a9354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac0a00a3c9d71244d689647ae89fd0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e9dcd5fe49427ba1894c9416113195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba45848ce6ff6f931145dcfcf0a94d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fc4506f05631ae69b8d16b51cbe24ee
publicationDate 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2742655-C1
titleOfInvention Method for the production of immunoglobulins for intravenous administration
abstract FIELD: biotechnology.SUBSTANCE: invention relates to biotechnology and namely to a method for producing immunoglobulins. The invention can be used in medicine. The method includes the division of human plasma into fractions to obtain a fraction and subsequent passage through anionic chromatography A, anionic chromatography B, and affinity chromatography C.EFFECT: invention makes it possible to obtain an immunoglobulin suitable for intravenous administration.17 cl, 1 dwg, 2 tbl, 18 ex
priorityDate 2018-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015001277-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013007740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2614119-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011038894-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425953283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379

Total number of triples: 52.